Zhenying W. Chen
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Multicenter Real-World Analysis of Glofitamab in Relapsed/Refractory Primary CNS Lymphoma: Clinical Activity, CNS Penetration, and ctDNA Dynamics.
Journal: American journal of hematology
Published: January 22, 2026
99mTc-HP-Ark2 SPECT/CT imaging reveals dynamic HER2 regulation in trastuzumab resistance and its reversal by PI3K inhibition.
Journal: International journal of cancer
Published: August 07, 2025
Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma.
Journal: EJNMMI research
Published: March 17, 2025
68 Ga-Pentixafor PET in Combination With MRI Improves the Differential Diagnosis of Glioblastoma and Primary Central Nervous System Lymphoma.
Journal: Clinical nuclear medicine
Published: January 06, 2025
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study.
Journal: Signal transduction and targeted therapy
Published: April 09, 2024
[68Ga]Pentixafor PET/CT for staging and prognostic assessment of newly diagnosed multiple myeloma: comparison to [18F]FDG PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 05, 2023
Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease.
Journal: Mini reviews in medicinal chemistry
Published: May 21, 2022
[68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 05, 2021
Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT.
Journal: European radiology
Published: November 01, 2021
CXCR4-Directed PET/CT with [68Ga]Pentixafor in Central Nervous System Lymphoma: A Comparison with [18F]FDG PET/CT.
Journal: Molecular imaging and biology
Published: July 10, 2021
Epidemiological analysis and screening mode of breast cancer screening in Fujian province from 2015 to 2018
Journal: Zhonghua yi xue za zhi
Published: August 15, 2020
[99mTc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [18F]FDG PET/CT.
Journal: Annals of nuclear medicine
Published: September 07, 2018
Last Updated: 09/26/2026